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ABSTRACT 
Objective: The objective of the present study was to formulate and evaluate the floating in-situ gelling system of diltiazem hydrochloride. 
Methods: Sodium alginate based diltiazem hydrochloride floating in situ gelling systems were prepared by dissolving hydroxyl propyl methyl 
cellulose (HPMC) in 25% of water, to which calcium carbonate and diltiazem hydrochloride were added with stirring to form, a proper and a 
homogenous dispersion of diltiazem hydrochloride. Meanwhile, 30% of water was heated to 60 ˚C on a hot plate to dissolve sodium alginate and 
cooled to 40 ˚C. The resulting solution was added to HPMC solution and mixed well. To 5% of water at 60 ˚C, sodium methyl paraben was added and 
dissolved and cooled to 40 ˚C and was added to the above mixture and mixed well. The volume was adjusted finally to 100% with distilled water. 
Prepared formulae were evaluated for physicochemical properties, drug content, pH, in vitro gelling capacity, in vitro buoyancy, viscosity, water 
uptake and in vitro drug release. 
Results: Formulation variables such as type and concentration of viscosity enhancing polymer (sodium alginate) and HPMC affected the 
formulation viscosity, gelling properties, floating behavior, and in vitro drug release. Formulation F5 and F6 showed the floating time of 5 min and 
more than 20 h respectively. A significant decrease in the rate and extent of the drug release was observed with the increase in polymer 
concentration in in-situ gelling preparation. Formulation F4, F5, F6 were shown to have extended drug release until the end of 7 h.  
Conclusion: The prepared in situ gelling formulations of diltiazem hydrochloride could float in the gastric conditions and released the drug in a 
sustained manner. The present formulation was non-irritant, easy to administer along with good retention properties, better patient compliant and 
with greater efficacy of the drug. 
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Over the past 30 y, greater attention has been focused on the 
development of controlled and sustained drug delivery systems. The 
development of in situ gel systems have received considerable 
attention over the past few years due to the advantages are shown 
by this system like the ease of administration, reduced frequency of 
administration, improved patient compliance and comfort [1]. 
The in situ gel dosage form is a liquid before administration but 
converts into a gel that floats on gastric contents as it comes in 
contact with it [2]. Such gel conversions are due to one or more 
mechanisms such as physiological stimuli (e. g., temperature and 
pH), physical changes in biomaterials (e. g., diffusion of solvent and 
swelling) and chemical reactions (e. g., enzymatic, ionic and 
photoinitiated polymerization) [3].  
In situ gel formulations are one of the challenging drug delivery 
systems. Since various biodegradable polymers used for the 
formulation of In situ gels, faces many fabrication problems, difficult 
processability, use of organic solvents, burst effect and 
irreproducible drug release kinetics and the natural polymers show 
batch to batch variations [4]. 
Diltiazem hydrochloride is a calcium channel blocker which is 
widely used in the treatment of variant angina, hypertension, and 
supraventricular tachyarrhythmias. It works by relaxing the blood 
vessels so that heart does not have to pump as hard. It also increases 
the supply of blood and oxygen to the heart. High blood pressure is a 
common condition and when not treated it can cause damage to the 
brain, heart, blood vessels, kidney and other parts of the body. 
Damage to these organs may cause heart diseases, heart attack, 
heart failure, stroke, kidney failure, loss of vision. 
Diltiazem hydrochloride is freely soluble in distilled water, 
chloroform and methanol. It is rapidly absorbed (90 %) after oral 
administration, but availability is only 30%-40% in systemic 
circulation and bioavailability varies between individuals. It has an 
elimination half-life of 3-5 h and is slightly prolonged after multiple 
dosing. Based on the above physical, chemical, biopharmaceutical 
properties and clinical relevance, diltiazem hydrochloride was 
selected as the drug candidate for developing floating oral in-situ gel 
for releasing the drug in a sustained manner. The objective of the 
present study was to develop diltiazem hydrochloride floating in-
situ gel which provides sustained release of the drug for the 
management of hypertension or angina pectoris. 
MATERIALS AND METHODS 
Materials  
Diltiazem hydrochloride was purchased from Gluchem Chemicals, 
Hyderabad; Andhra Pradesh, sodium alginate was procured from 
Loba Chemicals Pvt. Limited, Mumbai, calcium carbonate and 
sodium bicarbonate were purchased from SD Fine-Chem limited, 
Mumbai, HPMC was purchased from Molychem, Mumbai, sodium 
citrate was procured from Qualigens, Mumbai, methylparaben and 
hydrochloric acid were purchased from Molychem, Mumbai. All 
other reagents were of analytical grade. 
Methods 
Preparation of in-situ gel 
Floating in-situ gel formulations of diltiazem hydrochloride were 
prepared using compositions given in table 1[5]. 
Evaluation 
Physicochemical properties 
The colour, odour and taste of the formulated in-situ gel of diltiazem 
hydrochloride were determined as per the senses. 
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Table 1: Composition of diltiazem hydrochloride In situ gel formulations 
Ingredients Formulations in mg 
F1 F2 F3 F4 F5 F6 
Diltiazem HCl 30 30 30 30 30 30 
HPMC 50 50 50 50 50 50 
Sodium alginate 50 100 150 200 250 300 
Calcium carbonate 50 50 50 50 50 50 
Sodium bicarbonate 50 50 50 50 50 50 
Sodium citrate 25 25 25 25 25 25 
Methyl paraben 10 10 10 10 10 10 
 
Determination of drug content 
Accurately, 10 ml of the formulation (containing the equivalent of 30 mg 
diltiazem hydrochloride) from different batches was measured and 
transferred to 100 ml volumetric flasks. To this 50-70 ml of 0.1 N HCl 
was added and sonicated for 30 min. Volume was adjusted to 100 ml. 
Complete dispersion of the contents was ensured visually and the 
dispersion was filtered using Whatman's filter paper. From this solution, 
10 ml of sample was withdrawn and diluted to 100 ml with 0.1N HCl. 
Contents of diltiazem hydrochloride were measured at a maximum 
absorbance at 237 nm using UV-Visible spectrophotometer [5]. 
pH measurement 
pH of the prepared formulations was measured using a calibrated 
digital pH meter at 27 ˚C [6]. 
In vitro gelation study 
To evaluate the formulation for their in vitro gelling capacity 
accurately measured 1 ml of the coloured formulation were added to 
5 ml of the gelation solution (0.1 N HCl, pH 1.2) at 37 ˚Cin a test tube 
with mild agitation that avoids breaking of formed gel. The in vitro 
gelling capacity was graded in three categories on the basis of the 
stiffness of the formed gel, gelation time and time period for which 
they formed gel remains as such (+) gels after few minutes, 
dispersed rapidly; (++) gelation immediate remains for few h; (+++) 
gelation immediate remains for an extended period. 
Measurement of viscosity of in-situ gelling system 
The viscosity of the dispersion was determined using a Brookfield digital 
viscometer (DV-E Viscometer). The samples (2 ml) were sheared at a 
rate of rpm/min using spindle number 1 at room temperature. Viscosity 
measurement for each sample was done in triplicate, with each 
measurement taking approximately 30 seconds [7-9]. 
In vitro floating study 
The in vitro floating study was carried out by introducing 10 ml of 
the formulation into a beaker containing 900 ml of 0.1 N HCl (pH 
1.2) at 37 ˚C without much disturbance. The time the formulation 
took to emerge on the medium surface (floating lag time) and the 
time the formulation constantly floated on the surface of the 
dissolution medium (Duration of floating) were recorded [10-12]. 
Measurement of water uptake 
The water uptake by the gel of selected formulation of sodium 
alginate was determined by a simple method. In this study, the in-
situ gel formed in 40 ml of 0.1 N HCl (pH 1.2) was used for each 
formulation the gel portion from the 0.1N HCl was separated, and 
the excess HCl solution was blotted out with a tissue paper. The 
initial weight of the gel taken was weighed, and to this gel, 10 ml of 
distilled water was added and after every 30 min of the interval 
water was decanted and the weight of the gel was recorded and the 
difference in the weight was calculated [13,14].  
In vitro drug release study 
The dissolution studies were performed in triplicate using type I 
(basket method) dissolution apparatus. The dissolution medium 
used was 900 ml of 0.1 N HCl maintained at 37 ˚C. The stirring rate 
was adjusted to 50 rpm. This speed was believed to stimulate the in 
vivo existing mild agitation and was slow enough to avoid the 
breaking of gelled formulation. At predetermined time intervals 1 ml 
samples were withdrawn and replaced by fresh dissolution medium, 
filtered through what Mann’s filter paper, diluted and assayed at a 
maximum absorbance at 237 nm using double beam UV-Visible 
spectrophotometer [15-17]. 
RESULTS AND DISCUSSION 
In this study, six formulations of sodium alginate based floating oral 
in-situ gelling systems of diltiazem hydrochloride were prepared 
using sodium alginate as release retarding gel forming a polymer. 
Viscosity enhancing polymer HPMC was added to sodium alginate 
solution in an attempt to improve viscosity and to obtain slower 
drug release than those formulations containing sodium alginate 
alone. Calcium carbonate was used as a source of calcium ions and as 
a gas generating agent [18]. In addition sodium, bicarbonate was 
also included in the formulations as an additional gas generating 
agent to enhance floating behaviour of the In situ gelling system of 
diltiazem hydrochloride. 
Physicochemical properties 
The formulated oral In situ gelling system of diltiazem hydrochloride 
was found to be off white in colour with characteristic odour and a 
bland taste. 
Drug content 
The percentage drug content for all formulation was determined and 
shown in table 2. The drug content was found to be in the range of 
105-120% for all the formulations indicating a uniform distribution 
of the drug. 
pH measurement 
The measurement of pH is very important for oral preparations. 
Otherwise, it leads to irritation to the throat. All the formulations 
had a slightly alkaline pH. The pH of formulations was found in the 
range of 8.15-8.30 as shown in table 2. 
 
Table 2: Evaluation of in-situ gel (n=3) (average±SEM) 
Formulation code Drug content (%) pH Gelling study Floating lag time (min) Duration of floating Viscosity (cps) 
F1 109.2±0.51 8.15±0.03 (+) _ Did not float 4.97±0.01 
F2 105.9±0.44 8.26±0.03 (+) _ Did not float 22.093±0.01 
F3 108.2±0.38 8.27±0.02 (+) _ Did not float 884.269±0.01 
F4 118.2±0.44 8.29±0.01 (++) _ Did not float 1595.5±0.09 
F5 119.5±0.31 8.25±0.02 (+++) 3 5 min >1595.5 
F6 120±0.43 8.30±0.03 (+++) 10 >20 h >1595.5 
Gelling Study: (+) Gels after few minutes dispersed rapidly, (++) Gelation immediate remains for 12 h, (+++) Gelation immediate remains for more than 12 h 
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In vitro gelation study 
Gelling studies were carried out using 0.1N HCl/pH 1.2 and the obtained 
data were represented in table 2. Gelation occurs when the insoluble 
calcium carbonate solubilize when it comes in contact with acidic 
medium releasing carbon dioxide and calcium ions. The calcium ions 
interact with the anionic polymer (sodium alginate) in the formulation 
causing instantaneous gelation and provide a gel barrier that restricts 
drug release [18].  
It was noted that formulation F5 and F6 containing 250 mg and 300 mg 
of sodium alginate resulted in the gelation which remained for more 
than 12 h providing the sustained release of the drug, which concludes 
that as the concentration of anionic polymer increases the gelling 
capacity also increases. 
Viscosity studies 
The formulation should have an optimum viscosity that will allow ease 
of administration and swallowing as a liquid and produce satisfactory 
gel strength for use as a delivery vehicle. Results of viscosity for 
formulations F1 to F6 are shown in table 2. The formulations showed 
an increase in viscosity with increasing the concentration of gel 
forming polymer sodium alginate as a consequence of the increase in 
chain interaction. The concentration of sodium alginate (250 mg and 
300 mg) was found to produce a satisfactory viscosity increase which 
provides sustained release of the drug. Calcium carbonate also 
contributes to increasing the viscosity of the formulations.  
In vitro floating study  
The formulated floating in-site gelling system of diltiazem 
hydrochloride employed NaHCO3 or CaCO3 as a gas generating 
agent. The in vitro floating test revealed the ability of F6 
formulation to maintain buoyant for more than 12 h (table 2). 
Regarding the floating lag time, it was observed that formulae F5 
and F6 showed floating within 3 and 10 min respectively. The 
basic mechanism behind floating was because calcium carbonate 
solubilized and effervesced upon contact with acidic medium 
releasing calcium ion and carbon dioxide (CO2). The evolved CO2 
gas was entrapped in the gel causing floatation. The incorporation 
of sodium bicarbonate improves floating behavior by providing an 
additional source for CO2 gas generation [19, 20]. The calcium ion 
reacted with polymers produced a cross-linked three-dimensional 
gel network and swelled structure of polymers might restrict the 
further diffusion of CO2 and drug molecule and has resulted in an 
extended period of floating lag time and drug release of the 
formulation (F5 and F6) respectively.  
Measurement of water uptake by the gel  
The formulation exhibited water uptake which is observed in the 
range of 10-107% as shown in table 3. The release of the drug 
from the polymer matrix depends on the amount of water 
associated with the system. The release of the drug may involve 
the penetration of the water into the matrix and simultaneously 
release the drug via diffusion or dissolution. The water associated 
with the formulation at any point in the time can be determined by 
the simple test for all the formulation of sodium alginate based in-
situ gel of diltiazem hydrochloride. From the study, it was 
concluded that formulation F6 containing 300 mg of the sodium 
alginate resulted in 100% water uptake, in turn, a good release of 
the drug from the polymer. 
 
Table 3: Water uptake by gel (n=3) (average±SEM) 
Formulation code F1 F2 F3 F4 F5 F6 
Initial Wt (g) 10.04±0.14 10.26±0.03 10.48±0.03 11.3±0.04 16.22±0.0.04 18.49±0.02 
Time (H) Water gain (g) 
0 10.04±0.06 10.26±0.26 10.48±0.05 11.3±0.03 16.22±0.04 18.49±0.03 
1 11.6±0.09 12.22±0.06 12.08±0.02 10.84±0.03 17.11±0.04 21.44±0.03 
2 Dissolved Dissolved 12.52±0.02 10.89±0.02 18.27±0.02 28.99±0.02 
3 Dissolved Dissolved Dissolved 11.32±0.04 19.35±0.02 38.12±0.03 
4 Dissolved Dissolved Dissolved 13.06±0.03 20.40±0.03 38.40±0.02 
 
In vitro drug release study  
The in vitro release study of diltiazem hydrochloride from all six 
formulae in 0.1 NH4Cl was conducted for a period of 7 h and the result 
was shown in fig. 1. The effect of polymer concentration on in vitro 
drug release from the formulation is shown in fig. 1. A significant 
decrease in the rate and extent of the drug release was observed with 
the increase in polymer concentration in in-situ gelling preparation. 
These may be attributed to the increase in density of the polymer 
matrix and also an increase in diffusion path length which the drug 
molecules have to pass. The sodium alginate and HPMC with a primary 
role in the sol-gel phenomenon and buoyant also affected the release 
rate to some extent. Formulation F4, F5, F6 was shown to have 
extended drug release until the end of 7 h.  
 
 
Fig. 1: In vitro drug release of diltiazem hydrochloride gel (F1, 
F2, F3, F4, F5, F6) in 0.1 NH4Cl (n=3) (average±SEM) 
CONCLUSION  
In the present study, various in-situ gelling liquid oral formulation of 
diltiazem hydrochloride was prepared. The study as shown that by 
modifying the concentration of viscosity enhancing polymer and the use 
of HPMC, calcium carbonate, the release can be modulated to the desired 
rate. The incorporation of the sodium bicarbonate inappropriate amount 
was able to shorten the floating lag time and thereby affecting even the 
drug release behaviour from the in-situ gel. The prepared floating in-situ 
gel of diltiazem hydrochloride has the feasibility of sustaining the drug 
release while remaining in the stomach. So this system is of promising 
use in the treatment of angina pectoris. 
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